Amgen Inc (AMGN)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Amgen Inc (AMGN) Profile

Amgen Inc (AMGN.xnas) is a multinatiοnal biοpharmaceutical cοmpany headquartered in Thousand Oaks, California, United States. Amgen Inc is the wοrld’s largest independent biotechnοlοgy cοmpany in Ventura County, with 22,000 emplοyees and οne of the wοrld’s largest glοbally. Amgen operates on molecular biology and biochemistry, providing a healthcare business based on recombinant DNA technology. The company discovers, develops, manufactures and delivers innovative human therapeutics in 100 countries and regions worldwide, with its main therapeutic areas being cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Amgen stock (AMGN) is listed on the NASDAQ, had a market capitalisation of $130.03B (USD) as of January 2022 and $24.42B (USD) in 2020 yearly revenue. At the beginning of 2022, Amgen announced that the TEZSPIRE drug will be available for shipment to wholesalers in the U.S after the Food and Drug Administration (FDA) approval and the authorisation for LUMYKRAS from the European Commission (EC) for the treatment of advanced non-small-cell lung cancer. The same month Amgen and Arrakis Therapeutics announced a research collaboration on the discovery and development of RNA degrader therapeutics against a range of difficult-to-drug targets in multiple therapeutic areas.

Holding cost
Trading hours in US Eastern Time

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade Amgen Inc (AMGN) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

Start Trading
in Minutes

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Source - database | Page ID - 736

Get instant Updates in Telegram